β1 and β2 Adrenergic receptor polymorphisms: their impact on cardiovascular physiology, disease states, and response to therapeutic agents

Allen Namath, Craig Chen, Rani Agrawal, Andrew J. Patterson

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

The human genome project may revolutionize our understanding of many cardiovascular diseases and the medications we use to treat them. Why are there variations in disease severity? What causes disease progression in some individuals but not others? Why are there such dramatic differences in response to some therapeutic agents? The human genome project may soon help us answer these questions for patients with disorders ranging from hypertension to congestive heart failure.

Original languageEnglish (US)
Pages (from-to)2-9
Number of pages8
JournalSeminars in Anesthesia, Perioperative Medicine and Pain
Volume26
Issue number1
DOIs
StatePublished - Mar 2007

Keywords

  • Adrenergic receptor
  • Cardiomyopathy
  • Congestive heart failure
  • Haplotype
  • Hypertension
  • Myocardial infarction
  • Single nucleotide polymorphism
  • Sudden cardiac death
  • β Adrenergic receptor blocker

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint Dive into the research topics of 'β1 and β2 Adrenergic receptor polymorphisms: their impact on cardiovascular physiology, disease states, and response to therapeutic agents'. Together they form a unique fingerprint.

  • Cite this